Molecular remission in advanced acute promyelocytic leukaemia after treatment with the oral synthetic retinoid Tamibarotene.
Di Veroli
Ambra
A
Ramadan
Safaa M
SM
Divona
Mariadomenica
M
Cudillo
Laura
L
Giannì
Laura
L
Wieland
Scott
S
Giannotti
Federica
F
Mirabile
Milena
M
Arcese
William
W
Lo-Coco
Francesco
F
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D012008:Recurrence; D013764:Tetrahydronaphthalenes / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001565:Benzoates; D013764:Tetrahydronaphthalenes; C061133:tamibarotene